Status:

COMPLETED

Study To Investigate If Embody's Retinol Gummies Improve The Early Signs Of Skin Aging And Overall Skin Health

Lead Sponsor:

Embody Beauty, Inc.

Collaborating Sponsors:

Citruslabs

Conditions:

Acne, Adult

Eligibility:

All Genders

18-45 years

Phase:

NA

Brief Summary

The Embody retinol study is a single-arm clinical trial on skin aging prevention and adult acne. The purpose of this study is to determine the effect of a retinol gummy in adults aged 18-45 on skin ag...

Detailed Description

Embody has developed a retinol gummy with the aim to improve the appearance of early signs of aging, such as fine lines, dark spots, and sagging. Embody's retinol gummy has also the goal to reduce the...

Eligibility Criteria

Inclusion

  • Male or female between 18-45 years old
  • Must be in good general health
  • May experiences adult acne and/or early-stage wrinkles that are not treated by topical or oral prescription drugs/medication
  • Must maintain a basic skincare routine
  • Must discontinue the use of other dietary supplements
  • Must be willing to comply with the requirements of the protocol
  • Is able to communicate in English
  • Is willing to skip their normal skincare routine
  • Must provide written informed consent form (ICF)
  • Is willing and able to share feedback and take skin pictures via the used technology portal

Exclusion

  • Unwilling to provide consent
  • Unwilling to skip their normal skincare routine
  • Unwilling to follow the routine of the protocol
  • Use of other oral retinoids
  • Use of prescription medication relevant to the skin
  • Undergoing any cosmetic procedures during the study including Botox, laser or chemical treatments
  • Deep-set of wrinkles
  • History of the following medical conditions or diseases:
  • Kidney disease
  • Liver disease
  • Alcohol abuse
  • Use of prescription drug (topical or oral) that is targeted at any sort of skin condition (for example retinoids)
  • Any known allergies/sensitivities to nuts

Key Trial Info

Start Date :

January 19 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 15 2021

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT04884516

Start Date

January 19 2021

End Date

April 15 2021

Last Update

May 13 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Citruslabs

Santa Monica, California, United States, 90404